Observational Study
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Dec 15, 2022; 14(12): 2380-2392
Published online Dec 15, 2022. doi: 10.4251/wjgo.v14.i12.2380
Deep learning-based radiomics based on contrast-enhanced ultrasound predicts early recurrence and survival outcome in hepatocellular carcinoma
Zhe Huang, Zhu Shu, Rong-Hua Zhu, Jun-Yi Xin, Ling-Ling Wu, Han-Zhang Wang, Jun Chen, Zhi-Wei Zhang, Hong-Chang Luo, Kai-Yan Li
Zhe Huang, Zhu Shu, Jun-Yi Xin, Ling-Ling Wu, Hong-Chang Luo, Kai-Yan Li, Department of Medical Ultrasound, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China
Rong-Hua Zhu, Zhi-Wei Zhang, Institute of Hepato-pancreato-bililary Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China
Han-Zhang Wang, Jun Chen, PDx Advanced Applications, GE Healthcare, Shanghai 200020, China
Author contributions: Huang Z contributed to study concept and design, data acquisition, analysis, and interpretation, and manuscript drafting; Wang HZ and Chen J contributed to the implementation and analysis of all machine learning methods; Huang Z, Zhu S, Wu XB, and Zhu RH contributed to image interpretation and segmentation; Zhu S, Wu XB, Zhang ZW, and Li KY contributed to data acquisition; Huang Z, Li KY, Wang HZ, and Zhu RH contributed to study concept and design, critical revision of the manuscript for important intellectual content, and study supervision.
Institutional review board statement: The study was reviewed and approved by the Ethics Committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (Approval No. TJ-IRB20190401).
Informed consent statement: The Ethics Committee of Tongji Hospital waived the requirement to obtain written informed consent of all participants.
Conflict-of-interest statement: There are no conflicts of interest to report.
Data sharing statement: All data generated or analyzed during this study are included in this article and/or its supplementary material files. Further inquiries can be directed to the corresponding author.
STROBE statement: The authors have read the STROBE Statement—checklist of items, and the manuscript was prepared and revised according to the STROBE Statement—checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Kai-Yan Li, MD, Director, Doctor, Department of Medical Ultrasound, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 95 Jiefang Avenue, Qiaokou District, Wuhan 430030, Hubei Province, China. liky20006@126.com
Received: September 15, 2022
Peer-review started: September 15, 2022
First decision: October 19, 2022
Revised: October 21, 2022
Accepted: November 21, 2022
Article in press: November 21, 2022
Published online: December 15, 2022
Processing time: 87 Days and 15.1 Hours
ARTICLE HIGHLIGHTS
Research background

Hepatocellular carcinoma (HCC) is the most common primary liver malignancy.

Research motivation

To develop future treatment strategies, there is an urgent need to improve the identification of patients at high risk of recurrence and poor prognosis; this may help identify those who may benefit from adjuvant systemic therapy.

Research objectives

To predict early recurrence (ER) and overall survival (OS) in patients with HCC after radical resection using deep learning (DL)-based radiomics.

Research methods

A total of 414 consecutive patients with HCC who underwent surgical resection with available preoperative grayscale and contrast-enhanced ultrasound images were enrolled. The clinical, DLR, and clinical + DLR model were then designed to predict ER and OS.

Research results

The DLR model for predicting ER showed satisfactory clinical benefits [area under the curve (AUC)] = 0.819 and 0.568 in the training and testing cohorts, respectively), similar to the clinical model (AUC 0.580 and 0.520 in the training and testing cohorts, respectively; P > 0.05). The C-indices of the clinical + DLR model in prediction of OS in the training and testing cohorts were 0.800 and 0.759, respectively. The clinical + DLR model and the DLR model outperformed the clinical model in the training and testing cohorts (P < 0.001 for all). We divided patients into four categories by dichotomizing predicted ER and OS. For patients in class 1 (high ER rate and low risk of OS), retreatment (microwave ablation) after recurrence was associated with improved survival (hazard ratio = 7.895, P = 0.005).

Research conclusions

As compared to the clinical model, the clinical + DLR model significantly improves the accuracy of predicting OS in patients with HCC after radical resection.

Research perspectives

As compared to the clinical model, the clinical + DLR model significantly improves the accuracy of predicting OS in patients with HCC after radical resection.